Two years' experience with Dialock® and CLS™ (A new antimicrobial lock solution)

被引:51
作者
Sodemann, K [1 ]
Polaschegg, HD [1 ]
Feldmer, B [1 ]
机构
[1] Dialysis Ctr, Lahr Ettenheim, Germany
关键词
D O I
10.1159/000046950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:251 / 254
页数:4
相关论文
共 18 条
[11]  
NOSNER K, 1994, CHIR GASTROENTEROL, V10, P80, DOI 10.1159/000178454
[12]   VENOUS AIR-EMBOLISM - CLINICAL AND EXPERIMENTAL CONSIDERATIONS [J].
OREBAUGH, SL .
CRITICAL CARE MEDICINE, 1992, 20 (08) :1169-1177
[13]   ANTI-ENDO-TOXIN ACTIVITY OF TAUROLIN IN EXPERIMENTAL-ANIMALS [J].
PFIRRMANN, RW ;
LESLIE, GB .
JOURNAL OF APPLIED BACTERIOLOGY, 1979, 46 (01) :97-102
[14]  
REINMULLER J, 1999, HAMOSTASEOLOGIE, V19, P94
[15]   The hemodialysis catheter conundrum: Hate living with them, but can't live without them [J].
Schwab, SJ ;
Beathard, G .
KIDNEY INTERNATIONAL, 1999, 56 (01) :1-17
[16]  
Sesso R, 1998, J AM SOC NEPHROL, V9, P1085
[17]   TAUROLIDINE - IN-VITRO ACTIVITY AGAINST MULTIPLE-ANTIBIOTIC-RESISTANT, NOSOCOMIALLY SIGNIFICANT CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS, ENTEROCOCCUS-FAECIUM, AND DIVERSE ENTEROBACTERIACEAE [J].
TRAUB, WH ;
LEONHARD, B ;
BAUER, D .
CHEMOTHERAPY, 1993, 39 (05) :322-330
[18]   EFFECT OF THE ANTIENDOTOXIC AGENT, TAUROLIDINE, IN THE TREATMENT OF SEPSIS SYNDROME - A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL [J].
WILLATTS, SM ;
RADFORD, S ;
LEITERMANN, M .
CRITICAL CARE MEDICINE, 1995, 23 (06) :1033-1039